All In MedTech

FDA Clearance Tracker · P160034

Powerheart® AED G3 Pro

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Dec 6, 2018 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Dec 6, 2018

Approved

Time to decision

854 days

Received Aug 4, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P160034
Device name
Powerheart® AED G3 Pro
Applicant location
Chelsmford, MA
Received
Aug 4, 2016
Decided
Dec 6, 2018
Decision
Approved
Supplements
2 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 870.5310

Every decision under product code MKJ

FDA's approval statement

As written in FDA's record.

Approval for the Powerheart® AED G3 Pro.The Powerheart® AED G3 Pro is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are:1) unresponsive;2) not breathing normally; and3) without pulse.When the patient is a child or infant up to 8 years of age, or up to 55 lbs. (25kg), the device should be used with the Pediatric Defibrillation Pads. The therapy should not be delayed to determine the patient's exact age or weight.The Powerheart® AED G3 Pro is intended to be used by personnel who have been trained in its operation.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MKJ. The earliest in FDA's data is K853564, decided Oct 11, 1985.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for ZOLL Medical Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.